Form 4 for RGNX REGENXBIO Inc.

Accepted 2024-09-18 00:00:00 ET · period of report 2024-09-16 · accession 0001562180-24-006869 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-09-18	2024-09-16	RGNX	Chan Mitchell	CFO	A - Grant	$0.00	+58.9K	58.9K	New	$0
D	2024-09-18	2024-09-16	RGNX	Chan Mitchell	CFO	A - Grant	$0.00	+289.4K	289.4K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-09-16	A	A	58,869	$0.00	58,869	D	—	—	(F1) The restricted stock unit (RSU) award vesting commencement date shall be September 16, 2024. 1/4th of the shares subject to the RSU shall vest on each of the first, second, third and fourth anniversaries of the first day of the month in which the RSU was granted, subject to the continuous service of the recipient to the Issuer.
2	Derivative	Stock Options (Right to buy)	2024-09-16	A	A	289,362	$0.00	289,362	D	$12.74 · — to 2034-09-16	289,362 Common Stock	(F2) The option vesting commencement date shall be September 16, 2024. The options shall have a term of 10 years from the date of grant, subject to continuous service of the optionee to the Issuer. The options shall become exercisable as follows: with respect to 1/4th of the shares subject to the option when the optionee completes 12 months of continuous service to the Issuer after the vesting commencement date, and with respect to 1/48th of the shares subject to the option when the optionee completes each month of continuous service to the Issuer thereafter.